Kuehn Law investigates Picard Medical
Analysis based on 6 articles · First reported Jun 03, 2026 · Last updated Jun 09, 2026
The investigation and potential lawsuit against Picard Medical, Inc. could lead to a significant decline in its stock price due to investor concerns about fraud and insider trading. This event highlights risks in the biotechnology sector related to stock promotion schemes and corporate governance.
Kuehn Law, a shareholder litigation law firm, is investigating Picard Medical, Inc. for alleged breaches of fiduciary duties by its officers and directors. A federal securities lawsuit claims that insiders at Picard Medical, Inc. orchestrated a fraudulent stock promotion scheme involving social media misinformation and impersonated financial professionals. It is also alleged that insiders used offshore or nominee accounts to facilitate the dumping of shares during a price inflation campaign, and that Picard Medical, Inc.'s public statements and risk disclosures failed to mention these activities. Kuehn Law is encouraging investors who purchased shares prior to September 2, 2025, to contact the firm to enforce their rights.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard